Mechanisms of therapy-related carcinogenesis
- 18 November 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (12) , 943-955
- https://doi.org/10.1038/nrc1749
Abstract
Therapy-related cancers, defined as second primary cancers that arise as a consequence of chemotherapy and/or radiotherapy, are unusual in that they have a well-defined aetiology. Knowledge of the specific nature of the initiating exposure and exactly when it occurred has made it easier to identify crucial genetic events and to model these in vitro and in vivo. As such, the study of therapy-related cancers has led to the elucidation of discrete mechanisms of carcinogenesis, including DNA double-strand-break-induced gene translocation and genomic instability conferred by loss of DNA repair. Unsurprisingly, some of these mechanisms seem to operate in the development of sporadic cancers.Keywords
This publication has 115 references indexed in Scilit:
- Is mismatch repair really required for ionizing radiation–induced DNA damage signaling?Nature Genetics, 2004
- The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phaseOncogene, 2003
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- The Mammalian Mismatch Repair Pathway Removes DNA 8-oxodGMP Incorporated from the Oxidized dNTP PoolCurrent Biology, 2002
- Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated MLL Translocation BreakpointsBiochemistry, 2001
- A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancerOncogene, 1999
- Genetic instability in radiation-induced leukaemias: mouse modelsInternational Journal of Radiation Biology, 1998
- Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S6-MethylthioguanineBiochemistry, 1997
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990